PulpDigital.ai has entered into a licensing agreement with the Mayo Clinic to advance artificial intelligence solutions for chronic obstructive pulmonary disease (COPD) healthcare management. The initiative plans to leverage CairIQ, PulpDigital.ai’s flagship AI-driven platform, to address challenges in COPD management, including preventable hospital readmissions, medication adherence, care plan execution, patient engagement, and reducing provider burnout by minimizing low-value administrative tasks.